date:Aug 19, 2014
Corbion has reported Q2 2014 sales of 188.3 million, down 0.9% compared to Q2 2013. Organic sales growth was 1.1%, mostly driven by the Biochemicals market segment with organic growth of 13.3%. The Biobased Food Ingredients market segment declined organically by 2.2%. EBITDA in Q2 2014 decreased by 2.9% to 26.4 million. Organic EBITDA growth in Q2 2014 amounted to 3.4%.
Both sales and EBITDA grew organically in the second quarter compared to Q2 2013, said Tjerk de Ruiter, CEO. Similar to the fi